Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide efficacy and safety in relapsing multiple sclerosis with interferon-beta 1a calibrator
2007-004452-36Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of teriflunomide in multiple sclerosis (MS) (4 arms), sponsored by Sanofi. Primary endpoint: Annualized relapse rate. Started Feb 2008; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-004452-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004452-36.